4D Molecular Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 5.25 M | $48.87 M | 13.19% | 9.06% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 5.05 M | $47.01 M | -10.67% | 8.72% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 4.21 M | $39.15 M | -2.27% | 7.26% |
| BLACKROCK, INC. | 05/13/2026 | 4.15 M | $38.59 M | 1.98% | 7.16% |
| NOVO HOLDINGS A/S | 05/15/2026 | 3.65 M | $33.99 M | 0.00% | 6.30% |
| BVF INC/IL | 05/15/2026 | 2.88 M | $26.81 M | -37.80% | 4.97% |
| STATE STREET CORP | 05/15/2026 | 2.71 M | $25.21 M | 0.71% | 4.67% |
| 05/15/2026 | 2.20 M | $20.44 M | 100.00% | 3.79% | |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 2.00 M | $18.62 M | 3.31% | 3.45% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 1.61 M | $14.94 M | 29.96% | 2.77% |
| FEDERATED HERMES, INC. | 05/11/2026 | 1.43 M | $13.33 M | -11.01% | 2.47% |
| 05/15/2026 | 1.30 M | $12.13 M | 100.00% | 2.25% | |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.07 M | $9.92 M | 5.27% | 1.84% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 974.17 K | $9.07 M | 17.01% | 1.68% |
| EVERGREEN QUALITY FUND GP, LTD. | 05/15/2026 | 951.47 K | $8.86 M | 0.00% | 1.64% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 708.04 K | $6.59 M | 0.54% | 1.22% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 578.27 K | $5.38 M | 12.74% | 1.00% |
| NUVEEN, LLC | 04/30/2026 | 561.81 K | $5.23 M | 253.85% | 0.97% |
| 05/15/2026 | 555.83 K | $5.17 M | 100.00% | 0.96% | |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 522.82 K | $4.86 M | 77.32% | 0.90% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2026 | 522.58 K | $4.87 M | 3.80% | 0.90% |
| RTW INVESTMENTS, LP | 05/15/2026 | 475.74 K | $4.43 M | 0.00% | 0.82% |
| JPMORGAN CHASE & CO | 05/13/2026 | 415.66 K | $3.56 M | 48.71% | 0.72% |
| PROPEL BIO MANAGEMENT, LLC | 05/14/2026 | 380.42 K | $3.58 M | 100.00% | 0.66% |
| MORGAN STANLEY | 05/15/2026 | 345.41 K | $3.22 M | -48.65% | 0.60% |
| NORTHERN TRUST CORP | 05/14/2026 | 342.03 K | $3.18 M | 8.99% | 0.59% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 328.38 K | $3.06 M | -7.08% | 0.57% |
| INVESCO LTD. | 05/12/2026 | 310.68 K | $2.89 M | 102.87% | 0.54% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 05/15/2026 | 275.00 K | $2.56 M | 0.00% | 0.47% |
| VANGUARD FIDUCIARY TRUST CO | 05/15/2026 | 269.30 K | $2.51 M | 100.00% | 0.46% |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 266.15 K | $2.48 M | -44.26% | 0.46% |
| CITADEL ADVISORS LLC | 05/15/2026 | 264.10 K | $2.46 M | 1,227.85% | 0.46% |
| PEAPOD LANE CAPITAL LLC | 05/04/2026 | 241.48 K | $2.21 M | -9.90% | 0.42% |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2026 | 202.86 K | $1.89 M | -58.21% | 0.35% |
| WOODLINE PARTNERS LP | 05/15/2026 | 200.00 K | $1.86 M | 0.00% | 0.35% |
| PRIVIUM FUND MANAGEMENT B.V. | 05/05/2026 | 170.26 K | $1.59 M | -18.93% | 0.29% |
| UBS GROUP AG | 05/05/2026 | 158.12 K | $1.47 M | -31.64% | 0.27% |
| PERIGON WEALTH MANAGEMENT, LLC | 04/10/2026 | 146.20 K | $1.36 M | 0.04% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 133.61 K | $1.24 M | -2.29% | 0.23% |
| EXOME ASSET MANAGEMENT LLC | 05/15/2026 | 130.56 K | $1.22 M | 100.00% | 0.23% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 124.32 K | $1.16 M | -63.17% | 0.21% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 124.23 K | $1.16 M | -1.42% | 0.21% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 116.71 K | $1.09 M | 0.00% | 0.20% |
| OPALEYE MANAGEMENT INC. | 05/15/2026 | 112.29 K | $1.05 M | 100.00% | 0.19% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 108.87 K | $1.01 M | -16.41% | 0.19% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 101.51 K | $945.07 K | 11.45% | 0.18% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 101.11 K | $941.33 K | -37.58% | 0.17% |
| XTX TOPCO LTD | 05/15/2026 | 83.41 K | $776.50 K | 28.27% | 0.14% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/20/2026 | 83.33 K | $775.83 K | -71.87% | 0.14% |
| RAFFERTY ASSET MANAGEMENT, LLC | 05/15/2026 | 71.40 K | $664.70 K | -14.41% | 0.12% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
4D Molecular Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 187 institutional investors and hedge funds held shares of 4D Molecular Therapeutics Inc. The most heavily invested institutionals were:
JANUS HENDERSON GROUP PLC: 5.25 M
RA CAPITAL MANAGEMENT, L.P.: 5.05 M
GOLDMAN SACHS GROUP INC: 4.21 M
BlackRock, Inc.: 4.15 M
Novo Holdings A/S: 3.65 M
BVF INC/IL: 2.88 M
87.38% of 4D Molecular Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 55.10 M shares in the last 24 months. This purchase volume represents approximately $481.04 M in transactions.